Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke

Summary

The primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) and Mexidol® FORTE 250 (film-coated tablets, 250 mg) in the hyperacute and acute periods of ischemic stroke, and to evaluate their impact on clinical and neuroimaging outcomes of the disease.

Timeline

Start

2025-11-04

Primary completion

2027-04

Completion

2027-04

Drugs

Indications